Skip to main content
Log in

Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

Intravenous application of 100 µg synthetic ovine corticotropin releasing factor (CRF) led to stimulation of ACTH-secretion in nine normal controls, with a maximum 30 min after CRF. Cortisol, corticosterone, cortisone and 11-deoxycortisol increased with a maximum at 60 min after CRF, whereas no rise was seen in aldosterone, 11-deoxycorticosterone, 17-α-hydroxyprogesterone, progesterone, DHEA-S and testosterone. The specificity of CRF-stimulation was also shown by unchanged TSH, LH, FSH, hGH, prolactin and thyroid hormone levels, als well as unchanged insulin and gastrin levels. No serious side-effects were observed during the test period and afterwards.

CRF-tests were performed in ten patients with disturbances of the hypothalamo pituitary adrenal axis (HPAA). Preliminary findings show hyperresponsiveness of ACTH in all situations of ACTH-hypersecretion (two patients with Cushing's disease, one patient with Nelson's syndrome, and one with Addison's disease). In contrast, one patient with successful microadenomectomy showed no response of ACTH to CRF, whereas in another patient with a macroadenoma ACTH and cortisol-levels still increased postoperatively. Divergent patterns in ACTH-responsiveness to CRF were seen in four patients with secondary adrenal insufficiency, allowing the localization of the defect. These data point to the possible importance of the “CRF-test” as a differential diagnostic tool and prognostic factor in diseases of the HPAA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77–79

    Google Scholar 

  2. Burgus R, Dunn Th F, Desiderio D, Ward DN, Vale W, Guillemin R (1970) Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor. Nature 226:321–325

    Google Scholar 

  3. Burgus R, Butcher M, Amoss M, Ling N, Monahan M, Rivier J, Fellows R, Blackwell R, Vale W, Guillemin R (1972) Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF). Proc Nat Acad Sci USA 69:278–282

    Google Scholar 

  4. Fisher LA, Rivier J, Rivier C, Spiess J, Vale W, Brown MR (1982) Corticotropin-releasing factor (CRF): Central effects on mean arterial pressure and heartrate in rats. Endocrinology 110:2222–2224

    Google Scholar 

  5. Grossman A, Nieuwenhuysen Krusemann AG, Perry L, Tomlin S, Schally AV, Coy DH, Rees LH, Comaru-Schally AM, Besser GM (1982) New hypothalamic hormone, corticotropin-releasing factor specifically stimulates the release of adrenocorticotropic hormone and cortisol in man. Lancet 1:921–922

    Google Scholar 

  6. Guillemin R, Rosenberg B (1955) Humoral hypothalamic control of anterior pituitary: Study with combined tissue cultures. Endocrinology 57:599–607

    Google Scholar 

  7. Harris GW (1948) Neural control of the pituitary gland. Physiol Rev 28:139–173

    Google Scholar 

  8. Leyendecker G, Wildt L, Hansmann M (1980) Pregnancies following intermittent (pulsatile) administration of Gn-RH by means of a portable pump (“Zyklomat”) — a new approach to the treatment of infertility in hypothalamic amenorrhea. J Endocrinol Metab 51:1214–1216

    Google Scholar 

  9. Linton EA, Gillies GE, Lowry PJ (1982) Synergism between vasopressin and the new 41 residue corticotrophic releasing factor. Abstracts of the 64th annual meeting of the Endocrine Society, SF, Ca (Abstract 16)

  10. Müller OA, Fink R, Baur X, Ehbauer M, Madler M, Scriba PC (1978) ACTH im Plasma: Extraktion und Bestimmung. GIT Labormed 2:117–124

    Google Scholar 

  11. Müller OA (1980) ACTH im Plasma: Bestimmungsmethoden und klinische Bedeutung. Thieme, Stuttgart

    Google Scholar 

  12. Müller OA, Fahlbusch R (1982) Zentrales Cushing-Syndrom: Therapie und Verlauf. Verh Dtsch Ges Inn Med 88:1114–1118

    Google Scholar 

  13. Odell WD, Swerdloff RS (1978) Abnormalities of gonadal function in men. Clin Endocrinol (Oxf) 8:149–180

    Google Scholar 

  14. Pickardt CR, Horn K, Scriba PC (1972) Moderne Aspekte der Schilddrüsenfunktionsdiagnostik Serum-T3-Spiegel und TRH-Stimulationstest mit radioimmunologischer TSH-Bestimmung. Internist (Berl) 13:133–140

    Google Scholar 

  15. Rivier C, Brownstein M, Spiess J, River J, Vale W (1982) In vitro corticotropin-releasing-factor-induced secretion of adrenocorticotropin, beta-endophine and corticosterone. Endocrinology 110:272–278

    Google Scholar 

  16. Saffran M, Schally AV (1955) The release of corticotrophin by anterior pituitary in vivo. Can J Biochem Physiol 33:408–415

    Google Scholar 

  17. Schally AV, Redding TW, Bowers CY, Barrett HJF (1969) Isolation and properties of porcine thyreotropine-releasing hormone. J Biol Chem 244:4077–4088

    Google Scholar 

  18. Schally AV, Arimura A, Baba Y, Nair RMG, Matsuo H, Redding TW, Debeljuk L, White WF (1971) Isolation and properties of the FSH and LH-releasing hormone. Biochem Biophys Res Commun 43:393–399

    Google Scholar 

  19. Sippell WG, Bidlingmeier F, Becker H, Brunig T, Dörr H, Hehn H, Goldes W, Hollmann G, Knorr D (1978) Simultaneous radioimmunoassay of plasma aldosterone, corticosterone, 11-deoxycorticosterone, progesterone, 17-hydroxyprogesterone, 11-deoxycortisol, cortisol and cortisone. J Steroid Biochem 9:63–74

    Google Scholar 

  20. Stalla GK, Giesemann G, Müller OA, Wood WG, Scriba PC (1981) The development of a direct homologous radioimmunoassay for serum cortisol. J Clin Chem Biochem 19:427–434

    Google Scholar 

  21. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphine. Science 213:1394–1397

    Google Scholar 

  22. White MC, Adams EF, Loizou M, Mashiter K, Fahlbusch R (1982) Corticotropin releasing factor stimulates ACTH-release from human pituitary corticotropic tumour cells in culture. Lancet 2:1251–1252

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Mit Unterstützung der Deutschen Forschungsgemeinschaft (Sonderforschungsbereich 51)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müller, O.A., Dörr, H.G., Hagen, B. et al. Corticotropin releasing factor (CRF)-stimulation test in normal controls and patients with disturbances of the hypothalamo-pituitary-adrenal axis. Klin Wochenschr 60, 1485–1491 (1982). https://doi.org/10.1007/BF01716099

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01716099

Key words

Navigation